A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)

NCT06701513 · clinicaltrials.gov ↗

RECRUITING

Status

350

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Deucravacitinib

Sponsor

Bristol-Myers Squibb